# Ronald Feld

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/ronald-feld/

## Facts

| Field | Value |
| --- | --- |
| Citations | 18,518 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 68 |
| i10-index | 175 |
| Last Known Institution | University Health Network |
| OpenAlex ID | https://openalex.org/A5007824491 |
| Works | 302 |

## Researcher papers

- [Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.](https://scholariq.org/papers/chemotherapy-can-prolong-survival-in-patients-with-advanced-non-small-cell-lung/)
- [Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study](https://scholariq.org/papers/durvalumab-as-third-line-or-later-treatment-for-advanced-non-small-cell-lung/)
- [First-Line Erlotinib Followed by Second-Line Cisplatin-Gemcitabine Chemotherapy in Advanced Non–Small-Cell Lung Cancer: The TORCH Randomized Trial](https://scholariq.org/papers/first-line-erlotinib-followed-by-second-line-cisplatin-gemcitabine-chemotherapy/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Neutropenia and Cancer Infections](https://scholariq.org/topics/neutropenia-and-cancer-infections/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)

## Researcher university

- [University Health Network](https://scholariq.org/institutions/university-health-network/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.